Texas A&M Researchers Develop Nasal Spray to Reverse Brain Aging

Researchers at Texas A&M University have developed an innovative intranasal therapy that shows significant promise in reversing markers of brain aging. By utilizing extracellular vesicles (EVs) loaded with regulatory microRNAs, the team successfully delivered a treatment directly to the brain, bypassing the blood-brain barrier without the need for invasive procedures. The study, published in the Journal of Extracellular Vesicles, indicates that just two doses of this spray can reduce chronic inflammation and restore cognitive function in aging models.

The therapy functions by targeting the biological drivers of "neuroinflammaging," a state of persistent, low-level inflammation that impairs memory and cognitive flexibility. Specifically, the treatment suppresses inflammatory pathways such as the NLRP3 inflammasome and the cGAS-STING signaling system. Furthermore, the researchers observed a restoration of mitochondrial activity, effectively replenishing the energy supply required for neurons to process and store information efficiently. This dual-action approach—reducing inflammation while boosting cellular energy—appears to be the key to the observed cognitive improvements.

This breakthrough has profound implications for the future of geriatric medicine and neurodegenerative disease management. By demonstrating that age-related cognitive decline may be reversible rather than inevitable, the researchers have opened a new pathway for treating conditions like Alzheimer’s and dementia. If these results are successfully translated into human clinical trials, this non-invasive nasal delivery system could provide a scalable and accessible method for maintaining mental acuity and improving the quality of life for an aging global population.